Optimization of Polymeric Nanoparticles Encapsulating Peptide Nucleic Acids for In Utero Gene Editing of the Fetal Brain.
封装肽核酸的聚合物纳米颗粒的优化,用于胎儿大脑的子宫内基因编辑。
基本信息
- 批准号:10671586
- 负责人:
- 金额:$ 5.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-16 至 2024-08-15
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAffectAffinityAmniotic FluidAreaBase SequenceBindingBiodistributionBrainCRISPR/Cas technologyCellsCharacteristicsChildhoodClinical TrialsCognitiveConfocal MicroscopyDNADNA Sequence AlterationDataDevelopmentDiseaseDisorder of neurometabolic regulationEmbryoEncapsulatedEngineeringEpilepsyExposure toFDA approvedFetal DevelopmentFetusFlow CytometryFluorescent DyesFormulationGenesGeneticGestational AgeGlycolatesGreen Fluorescent ProteinsHarvestHemoglobinHumanImmune responseInjectionsInterventionKineticsKnowledgeLibrariesLife ExpectancyLinkMethodsModificationMolecularMotorMucopolysaccharidosis I HMusMutationNeurodevelopmental DisorderNeurologic SymptomsNeuronsNewborn InfantNucleic AcidsPathologic ProcessesPenetrationPeptide Nucleic AcidsPolyethylene GlycolsPolymerase Chain ReactionPolymersPopulationPreventive treatmentReporterResistanceRett SyndromeRiskRouteSafetySensorySiteStructure of omphalomesenteric veinSurfaceSymptomsTherapeuticTherapeutic AgentsTimeTrainingViral VectorWorkautism spectrum disorderbeta Globinbrain tissueclinical translationcurative treatmentsdevelopmental diseasedigitaldisease phenotypefetalfetal medicinefunctional groupgene therapyimmunogenicityimprovedin uteroin vivoinfancyinnovationintravenous injectionmouse modelnanoparticlenanopolymernervous system disorderneuralneurodevelopmentneurogeneticsnovelnucleasepoly(lactic acid)polyglycerolpostmitoticpregnantprenatalpreventpreventive interventionskillssocialstandard of carestemstem cellssynthetic nucleic acidtargeted agenttargeted deliverytargeted treatmenttranslational applicationsuptake
项目摘要
PROJECT SUMMARY: Neurogenetic developmental diseases (NDD) such as Rett syndrome are severe
neurological disorders that affect thousands of newborn infants each year. As the current standard of care for
most NDDs is focused on symptom mitigation, it is imperative that a preventative intervention is developed. The
genetic mutations associated with NDDs have been shown to cause abnormal neurodevelopment from very
early stages in fetal development. In utero gene therapy (IUGT) holds the promise of a treatment that could
intervene early on in this pathologic process and prevent the development of NDDs. IUGT is advantageous
because the plasticity and developmental immaturity of the fetus offers a window of opportunity that may be
exceptionally receptive to the therapeutic agents. Previous work in gene editing has largely focused on CRISPR-
Cas9 and viral vectors, which are associated with concerns of safety including off-target effects and
immunogenicity. To address these concerns, we propose that polymeric nanoparticles (NPs) encapsulating gene
editing peptide nucleic acids (PNAs) are a superior alternative. NPs made of FDA approved polymers have
excellent safety profiles, evidenced by their approval for clinical trials, and offer extended release and targeting
through surface modifications. Because PNAs are non-nuclease based, highly stable, and bind strongly, they
offer a method of inducing site-specific gene editing with a decreased risk of off-target editing effects. PNA-NPs
have been shown to be safe agents for gene editing in multiple translational applications. We hypothesize that
in utero delivery of PNA-NPs will result in safe, highly efficient gene editing of the fetal brain.
In my first aim, I will characterize the cellular and spatial biodistribution of NPs to the fetal brain after in
utero delivery through the amniotic fluid and the vitelline vein. I will create a library of NPs made of different
polymers and different sizes loaded with fluorescent dye. After administration of these NPs in utero to time dated
pregnant mice, I will harvest fetal brains and use confocal microscopy and flow cytometry for analysis. For my
second aim, I will demonstrate the feasibility of and optimize methods for in vivo gene editing in the fetal brain
after in utero delivery of PNA-NPs. In Sub Aim 2a, I will formulate NPs encapsulating a PNA sequence developed
by our lab to introduce a beta-globin mutation. These PNA-NPs will be used to treat differentiated, post-mitotic
neuronal Lund Human Mesencephalic cells (LUHMES) and gene editing will be evaluated using droplet digital
polymerase chain reaction (ddPCR). In Sub Aim 2b, I will formulate NPs based on the optimized characteristics
identified in Aim 1. These NPs will encapsulate a PNA that allows expression of Green Fluorescent Protein
(GFP) after successful gene editing. I will administer these NPs to GFP reporter fetuses in utero and analyze the
gene editing in the brain using confocal microscopy and flow cytometry. In demonstrating the safety and efficacy
of PNA-NPs as gene editing agents targeted to the fetal brain, our project will result in an important advance in
the potential of clinically translatable IUGT.
项目摘要:雷特综合征等神经遗传发育疾病 (NDD) 很严重
每年影响数千名新生儿的神经系统疾病。按照目前的护理标准
大多数 NDD 的重点是缓解症状,因此必须制定预防性干预措施。这
与 NDD 相关的基因突变已被证明会导致神经发育异常
胎儿发育的早期阶段。子宫内基因治疗(IUGT)有望成为一种治疗方法
尽早干预这一病理过程并预防 NDD 的发展。 IUGT有优势
因为胎儿的可塑性和发育不成熟提供了一个可能的机会之窗
对治疗剂特别容易接受。之前的基因编辑工作主要集中在 CRISPR-
Cas9 和病毒载体,与安全问题相关,包括脱靶效应和
免疫原性。为了解决这些问题,我们提出封装基因的聚合物纳米颗粒(NP)
编辑肽核酸 (PNA) 是一种更好的选择。由 FDA 批准的聚合物制成的 NP
卓越的安全性,通过临床试验的批准证明,并提供延长的释放和靶向
通过表面修饰。由于 PNA 是非核酸酶、高度稳定且结合力强,因此它们
提供了一种诱导位点特异性基因编辑的方法,同时降低了脱靶编辑效应的风险。纳米粒子
已被证明是多种翻译应用中基因编辑的安全剂。我们假设
PNA-NP 的子宫内递送将对胎儿大脑进行安全、高效的基因编辑。
在我的第一个目标中,我将描述纳米粒子在胎儿大脑中的细胞和空间生物分布。
通过羊水和卵黄静脉进行子宫分娩。我将创建一个由不同材料制成的 NP 库
聚合物和不同尺寸的负载荧光染料。在子宫内施用这些 NP 后的日期
怀孕的老鼠,我会收获胎儿大脑并使用共聚焦显微镜和流式细胞术进行分析。为了我的
第二个目标,我将展示胎儿大脑体内基因编辑的可行性和优化方法
PNA-NP 宫内分娩后。在子目标 2a 中,我将制定封装已开发的 PNA 序列的 NP
由我们的实验室引入β-珠蛋白突变。这些 PNA-NP 将用于治疗分化的、有丝分裂后的
神经元隆德人类中脑细胞(LUHMES)和基因编辑将使用液滴数字技术进行评估
聚合酶链反应(ddPCR)。在子目标2b中,我将根据优化后的特征制定NP
目标 1 中确定的。这些 NP 将封装允许表达绿色荧光蛋白的 PNA
(GFP) 成功基因编辑后。我将在子宫内对 GFP 报告基因胎儿施用这些 NP 并分析
使用共聚焦显微镜和流式细胞术在大脑中进行基因编辑。在证明安全性和有效性时
PNA-NPs 作为针对胎儿大脑的基因编辑剂,我们的项目将在
临床可转化的IUGT的潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anna Y Lynn其他文献
Anna Y Lynn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anna Y Lynn', 18)}}的其他基金
Optimization of Polymeric Nanoparticles Encapsulating Peptide Nucleic Acids for In Utero Gene Editing of the Fetal Brain.
封装肽核酸的聚合物纳米颗粒的优化,用于胎儿大脑的子宫内基因编辑。
- 批准号:
10468654 - 财政年份:2021
- 资助金额:
$ 5.2万 - 项目类别:
Optimization of Polymeric Nanoparticles Encapsulating Peptide Nucleic Acids for In Utero Gene Editing of the Fetal Brain.
封装肽核酸的聚合物纳米颗粒的优化,用于胎儿大脑的子宫内基因编辑。
- 批准号:
10313760 - 财政年份:2021
- 资助金额:
$ 5.2万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 5.2万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 5.2万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 5.2万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 5.2万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 5.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 5.2万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 5.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)